Analysis of the composition and influencing factors of hospitalization expenses for 1517 patients with lung malignant tumors in Beijing

Lili Zhao,Jiaji Tang

DOI: https://doi.org/10.1097/md.0000000000037385

IF: 1.6

2024-03-17

Medicine

Abstract:At present, China's residents' risk factors such as dyslipidemia rate, hypertension prevalence rate, obesity incidence rate, smoking rate, reduced physical activity, and other risk factors are maintained at a high level, and there is an upward trend, malignant tumors and other diseases caused by the loss of life of the residents may be further increased. [ 1–3 ] In the case of China's residents' consumption capacity improvement, the security system is gradually improved, the demand for tumor prevention and treatment will still be gradually released, which will bring the continuous growth of tumor treatment costs. Relevant studies show that patients often need to receive radiotherapy or chemotherapy 6 to 7 times after resection surgery for malignant tumors, with a significantly higher average annual number of hospitalizations and higher per capita treatment costs than that of patients with all diseases. [ 4 ] The accounting results show that the proportion of family health expenditure in oncology treatment costs is slightly less than 30% (the proportion of family health expenditure in outpatient oncology costs is close to 40%). Affected by the level of economic development, co-ordination efforts, financing methods, etc., the affordability of the health insurance fund in a certain region is relatively limited, from which the National Health Insurance Bureau has also clearly pointed out that: firstly, tumor-targeted drugs and other drugs need to be co-paid by the patients, and secondly, the health insurance fund has not been able to expand the scope of payment to cover non-therapeutic disease screening programs, including tumor screening and other non-therapeutic disease screening programs.

medicine, general & internal